103 related articles for article (PubMed ID: 29395794)
1. Folate receptor α is associated with poor clinicopathological perspectives in breast carcinoma.
Aboulhagag NAE; Torky RF; Fadel SA
Pathophysiology; 2018 Mar; 25(1):71-76. PubMed ID: 29395794
[TBL] [Abstract][Full Text] [Related]
2. Correlation of folate receptor alpha expression with clinicopathological parameters and outcome in triple negative breast cancer.
Zagorac I; Lončar B; Dmitrović B; Kralik K; Kovačević A
Ann Diagn Pathol; 2020 Oct; 48():151596. PubMed ID: 32829070
[TBL] [Abstract][Full Text] [Related]
3. Immunohistochemical expression of folate receptor alpha in colorectal carcinoma: patterns and biological significance.
Shia J; Klimstra DS; Nitzkorski JR; Low PS; Gonen M; Landmann R; Weiser MR; Franklin WA; Prendergast FG; Murphy L; Tang LH; Temple L; Guillem JG; Wong WD; Paty PB
Hum Pathol; 2008 Apr; 39(4):498-505. PubMed ID: 18342661
[TBL] [Abstract][Full Text] [Related]
4. Expression status of folate receptor alpha is a predictor of survival in pancreatic ductal adenocarcinoma.
Cai L; Michelakos T; Ferrone CR; Zhang L; Deshpande V; Shen Q; DeLeo A; Yamada T; Zhang G; Ferrone S; Wang X
Oncotarget; 2017 Jun; 8(23):37646-37656. PubMed ID: 28430580
[TBL] [Abstract][Full Text] [Related]
5. Folate Receptor α-Targeted
Heo GS; Detering L; Luehmann HP; Primeau T; Lee YS; Laforest R; Li S; Stec J; Lim KH; Lockhart AC; Liu Y
Mol Pharm; 2019 Sep; 16(9):3996-4006. PubMed ID: 31369274
[TBL] [Abstract][Full Text] [Related]
6. Correlation between the expression of folate receptor alpha (FRα) and clinicopathological features in patients with lung adenocarcinoma.
Tamura N; Fujiwara Y; Hashimoto T; Shiraishi H; Kitano S; Shimizu T; Kuwano K; Yamamoto N; Motoi N
Lung Cancer; 2020 Jul; 145():152-157. PubMed ID: 32450493
[TBL] [Abstract][Full Text] [Related]
7. High expression of folate receptor alpha is associated with poor prognosis in patients with cervical cancer.
Yazaki S; Kojima Y; Yoshida H; Takamizawa S; Kitadai R; Nishikawa T; Shimoi T; Sudo K; Saito A; Okuma HS; Tanioka M; Noguchi E; Uno M; Ishikawa M; Kato T; Fujiwara Y; Ohe Y; Yonemori K
J Gynecol Oncol; 2022 Nov; 33(6):e82. PubMed ID: 36245230
[TBL] [Abstract][Full Text] [Related]
8. Concordance of folate receptor-α expression between biopsy, primary tumor and metastasis in breast cancer and lung cancer patients.
Boogerd LS; Boonstra MC; Beck AJ; Charehbili A; Hoogstins CE; Prevoo HA; Singhal S; Low PS; van de Velde CJ; Vahrmeijer AL
Oncotarget; 2016 Apr; 7(14):17442-54. PubMed ID: 26943581
[TBL] [Abstract][Full Text] [Related]
9. Folate receptor alpha expression associates with improved disease-free survival in triple negative breast cancer patients.
Norton N; Youssef B; Hillman DW; Nassar A; Geiger XJ; Necela BM; Liu H; Ruddy KJ; Polley MC; Ingle JN; Couch FJ; Perez EA; Liu MC; Carter JM; Leon-Ferre RA; Boughey JC; Somers EB; Kalari KR; Visscher DW; Goetz MP; Knutson KL
NPJ Breast Cancer; 2020; 6():4. PubMed ID: 32047850
[TBL] [Abstract][Full Text] [Related]
10. Folate receptor alpha is widely expressed and a potential therapeutic target in uterine and ovarian carcinosarcoma.
Saito A; Nishikawa T; Yoshida H; Mizoguchi C; Kitadai R; Yamamoto K; Yazaki S; Kojima Y; Ishikawa M; Kato T; Yonemori K
Gynecol Oncol; 2023 Sep; 176():115-121. PubMed ID: 37506533
[TBL] [Abstract][Full Text] [Related]
11. Characterization of folate receptor alpha (FRα) expression in archival tumor and biopsy samples from relapsed epithelial ovarian cancer patients: A phase I expansion study of the FRα-targeting antibody-drug conjugate mirvetuximab soravtansine.
Martin LP; Konner JA; Moore KN; Seward SM; Matulonis UA; Perez RP; Su Y; Berkenblit A; Ruiz-Soto R; Birrer MJ
Gynecol Oncol; 2017 Nov; 147(2):402-407. PubMed ID: 28843653
[TBL] [Abstract][Full Text] [Related]
12. Protein Expression of Folate Receptor Alpha in Adenoid Cystic Carcinoma of the Head and Neck.
Schnoell J; Jank BJ; Kadletz-Wanke L; Stoiber S; Gurnhofer E; Schlederer M; Heiduschka G; Kenner L
Onco Targets Ther; 2022; 15():531-538. PubMed ID: 35601979
[TBL] [Abstract][Full Text] [Related]
13. Relation between Ki-67, ER, PR, Her2/neu, p21, EGFR, and TOP II-α expression in invasive ductal breast cancer patients and correlations with prognosis.
Yan J; Liu XL; Han LZ; Xiao G; Li NL; Deng YN; Yin LC; Ling LJ; Yu XY; Tan CL; Huang XP; Liu LX
Asian Pac J Cancer Prev; 2015; 16(2):823-9. PubMed ID: 25684532
[TBL] [Abstract][Full Text] [Related]
14. Folate Receptor Alpha Immunohistochemistry in Cytology Specimens of Metastatic Breast Carcinoma.
Sheikh UN; Cohen C; Siddiqui MT
Acta Cytol; 2015; 59(4):298-304. PubMed ID: 26413911
[TBL] [Abstract][Full Text] [Related]
15. Folate Receptor Overexpression in Human and Canine Meningiomas-Immunohistochemistry and Case Report of Intraoperative Molecular Imaging.
Pierce JT; Cho SS; Nag S; Zeh R; Jeon J; Holt D; Durham A; Nasrallah MP; Singhal S; Lee JYK
Neurosurgery; 2019 Sep; 85(3):359-368. PubMed ID: 30113687
[TBL] [Abstract][Full Text] [Related]
16. Alterations of estrogen receptors, progesterone receptors and c-erbB2 oncogene protein expression in ductal carcinomas of the breast.
Hussein MR; Abd-Elwahed SR; Abdulwahed AR
Cell Biol Int; 2008 Jun; 32(6):698-707. PubMed ID: 18296077
[TBL] [Abstract][Full Text] [Related]
17. IMP3 is a novel biomarker for triple negative invasive mammary carcinoma associated with a more aggressive phenotype.
Walter O; Prasad M; Lu S; Quinlan RM; Edmiston KL; Khan A
Hum Pathol; 2009 Nov; 40(11):1528-33. PubMed ID: 19695680
[TBL] [Abstract][Full Text] [Related]
18. Folate receptor α expression and significance in endometrioid endometrium carcinoma and endometrial hyperplasia.
Senol S; Ceyran AB; Aydin A; Zemheri E; Ozkanli S; Kösemetin D; Sehitoglu I; Akalin I
Int J Clin Exp Pathol; 2015; 8(5):5633-41. PubMed ID: 26191275
[TBL] [Abstract][Full Text] [Related]
19. [Expression of fatty acid synthase and its association with HER2 in invasive ductal carcinoma of breast].
Yang M; Xu SP; Ao QL
Zhonghua Bing Li Xue Za Zhi; 2013 Apr; 42(4):257-61. PubMed ID: 23928534
[TBL] [Abstract][Full Text] [Related]
20. NEDD4 expression is associated with breast cancer progression and is predictive of a poor prognosis.
Wan L; Liu T; Hong Z; Pan Y; Sizemore ST; Zhang J; Ma Z
Breast Cancer Res; 2019 Dec; 21(1):148. PubMed ID: 31856858
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
